Cargando…

Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation

BACKGROUND: Metabolic syndrome (MS) is a risk factor for stroke and thromboembolism event. Left atrial or LA appendage (LA/LAA) thrombus is a surrogate of potential stroke. The relationship between MS and atrial thrombus remains unclear. In this study, we sought to investigate the effect of MS on ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu-Yang, Liu, Qi, Liu, Li, Shu, Xiao-Rong, Su, Zi-Zhuo, Zhang, Hai-Feng, Nie, Ru-Qiong, Wang, Jing-Feng, Xie, Shuang-Lun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072249/
https://www.ncbi.nlm.nih.gov/pubmed/27748329
http://dx.doi.org/10.4103/0366-6999.191744
_version_ 1782461372611690496
author Chen, Yu-Yang
Liu, Qi
Liu, Li
Shu, Xiao-Rong
Su, Zi-Zhuo
Zhang, Hai-Feng
Nie, Ru-Qiong
Wang, Jing-Feng
Xie, Shuang-Lun
author_facet Chen, Yu-Yang
Liu, Qi
Liu, Li
Shu, Xiao-Rong
Su, Zi-Zhuo
Zhang, Hai-Feng
Nie, Ru-Qiong
Wang, Jing-Feng
Xie, Shuang-Lun
author_sort Chen, Yu-Yang
collection PubMed
description BACKGROUND: Metabolic syndrome (MS) is a risk factor for stroke and thromboembolism event. Left atrial or LA appendage (LA/LAA) thrombus is a surrogate of potential stroke. The relationship between MS and atrial thrombus remains unclear. In this study, we sought to investigate the effect of MS on risk stratification of LA/LAA thrombus formation in patients with nonvalvular atrial fibrillation (NVAF). METHODS: This cross-sectional study enrolled 294 consecutive NVAF patients without prior anticoagulant and lipid-lowering therapies. LA/LAA thrombus was determined by transesophageal echocardiography. Risk assessment of LA/LAA thrombus was performed using the CHADS(2), CHA(2)DS(2)-VASc, MS, CHADS(2)-MS, and CHA(2)DS(2)-VASc-MS scores. Logistic regression analyses were performed to determine which factors were significantly related to LA/LAA thrombus. Odds ratio (OR) including 95% confidence interval was also calculated. The predictive powers of different scores for the risk of LA/LAA thrombus were represented by C-statistics and compared by receiver operating characteristic (ROC) analysis. RESULTS: LA/LAA thrombi were identified in 56 patients (19.0%). Logistic analysis showed that MS was the strongest risk factor for LA/LAA thrombus in NVAF patients (OR = 14.698, P < 0.001). ROC curve analyses revealed that the C-statistics of CHADS(2)-MS and CHA(2)DS(2)-VASc-MS was significantly higher than those of CHADS(2) and CHA(2)DS(2)-VASc scores (CHADS(2)-MS vs. CHADS(2), 0.807 vs. 0.726, P = 0.0019). Furthermore, MS was helpful for identifying individuals with a high risk of LA/LAA thrombus in the population with a low risk of stroke (CHADS(2) or CHA(2)DS(2)-VASc score = 0). CONCLUSIONS: MS is associated with LA/LAA thrombus risk in patients with NVAF. In addition to the CHADS(2) and CHA(2)DS(2)-VASc scores, the CHADS(2)-MS and CHA(2)DS(2)-VASc-MS scores provide additional information on stroke risk assessment.
format Online
Article
Text
id pubmed-5072249
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-50722492016-11-01 Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation Chen, Yu-Yang Liu, Qi Liu, Li Shu, Xiao-Rong Su, Zi-Zhuo Zhang, Hai-Feng Nie, Ru-Qiong Wang, Jing-Feng Xie, Shuang-Lun Chin Med J (Engl) Original Article BACKGROUND: Metabolic syndrome (MS) is a risk factor for stroke and thromboembolism event. Left atrial or LA appendage (LA/LAA) thrombus is a surrogate of potential stroke. The relationship between MS and atrial thrombus remains unclear. In this study, we sought to investigate the effect of MS on risk stratification of LA/LAA thrombus formation in patients with nonvalvular atrial fibrillation (NVAF). METHODS: This cross-sectional study enrolled 294 consecutive NVAF patients without prior anticoagulant and lipid-lowering therapies. LA/LAA thrombus was determined by transesophageal echocardiography. Risk assessment of LA/LAA thrombus was performed using the CHADS(2), CHA(2)DS(2)-VASc, MS, CHADS(2)-MS, and CHA(2)DS(2)-VASc-MS scores. Logistic regression analyses were performed to determine which factors were significantly related to LA/LAA thrombus. Odds ratio (OR) including 95% confidence interval was also calculated. The predictive powers of different scores for the risk of LA/LAA thrombus were represented by C-statistics and compared by receiver operating characteristic (ROC) analysis. RESULTS: LA/LAA thrombi were identified in 56 patients (19.0%). Logistic analysis showed that MS was the strongest risk factor for LA/LAA thrombus in NVAF patients (OR = 14.698, P < 0.001). ROC curve analyses revealed that the C-statistics of CHADS(2)-MS and CHA(2)DS(2)-VASc-MS was significantly higher than those of CHADS(2) and CHA(2)DS(2)-VASc scores (CHADS(2)-MS vs. CHADS(2), 0.807 vs. 0.726, P = 0.0019). Furthermore, MS was helpful for identifying individuals with a high risk of LA/LAA thrombus in the population with a low risk of stroke (CHADS(2) or CHA(2)DS(2)-VASc score = 0). CONCLUSIONS: MS is associated with LA/LAA thrombus risk in patients with NVAF. In addition to the CHADS(2) and CHA(2)DS(2)-VASc scores, the CHADS(2)-MS and CHA(2)DS(2)-VASc-MS scores provide additional information on stroke risk assessment. Medknow Publications & Media Pvt Ltd 2016-10-20 /pmc/articles/PMC5072249/ /pubmed/27748329 http://dx.doi.org/10.4103/0366-6999.191744 Text en Copyright: © 2016 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Chen, Yu-Yang
Liu, Qi
Liu, Li
Shu, Xiao-Rong
Su, Zi-Zhuo
Zhang, Hai-Feng
Nie, Ru-Qiong
Wang, Jing-Feng
Xie, Shuang-Lun
Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation
title Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation
title_full Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation
title_fullStr Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation
title_full_unstemmed Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation
title_short Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation
title_sort effect of metabolic syndrome on risk stratification for left atrial or left atrial appendage thrombus formation in patients with nonvalvular atrial fibrillation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072249/
https://www.ncbi.nlm.nih.gov/pubmed/27748329
http://dx.doi.org/10.4103/0366-6999.191744
work_keys_str_mv AT chenyuyang effectofmetabolicsyndromeonriskstratificationforleftatrialorleftatrialappendagethrombusformationinpatientswithnonvalvularatrialfibrillation
AT liuqi effectofmetabolicsyndromeonriskstratificationforleftatrialorleftatrialappendagethrombusformationinpatientswithnonvalvularatrialfibrillation
AT liuli effectofmetabolicsyndromeonriskstratificationforleftatrialorleftatrialappendagethrombusformationinpatientswithnonvalvularatrialfibrillation
AT shuxiaorong effectofmetabolicsyndromeonriskstratificationforleftatrialorleftatrialappendagethrombusformationinpatientswithnonvalvularatrialfibrillation
AT suzizhuo effectofmetabolicsyndromeonriskstratificationforleftatrialorleftatrialappendagethrombusformationinpatientswithnonvalvularatrialfibrillation
AT zhanghaifeng effectofmetabolicsyndromeonriskstratificationforleftatrialorleftatrialappendagethrombusformationinpatientswithnonvalvularatrialfibrillation
AT nieruqiong effectofmetabolicsyndromeonriskstratificationforleftatrialorleftatrialappendagethrombusformationinpatientswithnonvalvularatrialfibrillation
AT wangjingfeng effectofmetabolicsyndromeonriskstratificationforleftatrialorleftatrialappendagethrombusformationinpatientswithnonvalvularatrialfibrillation
AT xieshuanglun effectofmetabolicsyndromeonriskstratificationforleftatrialorleftatrialappendagethrombusformationinpatientswithnonvalvularatrialfibrillation